Medical School - Penn State University College of Medicine, Hershey, PA
Residency - Internal Medicine, Johns Hopkins University, Baltimore, MD
Fellowship - Infectious Disease, University of Maryland, Baltimore, MD
MPH - Epidemiology, University of Maryland, Baltimore, MD

1. Weiser J, Tie Y, Crim S, Riedel DJ, Shousea RL, Dasgupta S. Clinical outcomes by provider type among people with HIV. J Acquir Immune Defic Syndr 2024; 96(2):180-189.
2. Thomas C, Yuan X, Taussig JA, Tie Y, Dasgupta S, Riedel DJ, Weiser J. Unmet needs for ancillary services by provider type among people with diagnosed human immunodeficiency virus. Open Forum Infect Dis 2024; 11(7):ofae284.
3. Sebeza J, Muiruri C, Riedel DJ, Stafford K, Omari H, Memiah P, Lavoie MC, Rwibasira G, Tuyishime S, Ntaganira J. Is the differentiated service delivery model suited to the needs of people living with HIV in Rwanda. AIDS Behav 2024;28(9):2941-2949.
4. Zafar SJ, Wynne Z, John T, Groft Buzzalino L, Shishido AA, Riedel DJ. Cefazolin-induced hemolytic anemia in septic arthritis. IDCases 2024;37:e02057.
5. Sebeza J, Ramadhan H, Riedel DJ, Memiah P, Lavoie MC, Negussie D, Tuyishime S, Nshogoza RG, Muiruri C, Stafford K. Effect of differentiated service delivery model on retention to care among people living with HIV in Rwanda: a retrospective cohort analysis. Rwanda J Med Health Sci 2025;8(1):6-16.
6. Remera E, Chammartin F, Nsanzimana S, Malamba SS, Rwibasira GN, Riedel DJ, Forrest JI, Mutesa L, Ford N, Ahmed A, Condo JU, Karera S, Mills EJ, Bucher HC. Factors associated with recent HIV infections among newly HIV diagnosed in Rwanda. J Acquir Immune Defic Syndr 2025;99(4):388-394.
7. Luo Q, Horner MJ, Haas CB, McGee-Avila JK, Pfeiffer RM, Engels EA, Pawlish K, Monterosso A, Riedel DJ, Wu XC, Gonsalves L, Speers S, Cohen C, Shiels MS. Differences in trends in cancer incidence rates among people with HIV during 2001–2019 by race and ethnicity and by risk group in the United States, Clin Infect Dis 2025;80(6):1355-1364.
8. Smith RD, Luethy PM, Riedel DJ. The pink road less traveled. Clin Infect Dis 2025; 81(4):815-817.
9. Duggirala M, Ibukun F, Smith R, Abdalla E, Sharifai N, Ashraf N, Riedel DJ. Violaceous lesion and pulmonary necrosis. Clin Infect Dis 2025; 81(5):1005-1007.
10. Mathur P, Chen H, Riedel DJ, Holland E, Palacio D, Bork JT, Prakash K, Hardy N, Kocoglu M, Badros A, Fromowitz A, Yared J, Rapoport AP, Atanackovic D, Baddley J. Changes in C-reactive protein forecast infection risk following treatment with Chimeric Antigen Receptor T cells. Cancers 2026; 18(18):2915.

Cancer in patients living with HIV
Improving clinical management of HIV and cancer
Disparities in cancer care and mortality between patients with and without HIV
International HIV care and treatment

HIV/AIDS medicine
Infectious Diseases
Cancer ID

Immunocompromised Hosts

https://www.medschool.umaryland.edu/osr/m4i/

http://www.ihv.org/ 

medschool.umaryland.edu/ciheb/

https://www.medschool.umaryland.edu/osr/m4i/ 

https://www.medschool.umaryland.edu/osr/frct/